EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Contribution of hypothalamic orexin (hypocretin) circuits to pathologies of motivation

Aida Mohammadkhani, Caitlin Mitchell, Morgan H James, Stephanie L Borgland, Christopher V Dayas

British Journal of Pharmacology · 2024-11 · 181 (22) · 4430-4449

DOI: 10.1111/bph.17325 ↗

At a glance

Übersichtsarbeit in British Journal of Pharmacology, published online on 2024-09-24. Written by Aida Mohammadkhani and 4 co-authors. Institution: Department of Physiology and Pharmacology, Hotchkiss Brain Institute, The University of Calgary, Calgary, Alberta, Canada. Major MEDLINE topics: Orexins, Motivation, Hypothalamus. Cited 20 times so far (Crossref); 209 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIEHS NIH HHS, Hunter Medical Research Institute, NIDA NIH HHS.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

The orexin (also known as hypocretin) system, consisting of neuropeptides orexin‐A and orexin‐B, was discovered over 25 years ago and was immediately identified as a central regulator of sleep and wakefulness. These peptides interact with two G‐protein coupled receptors, orexin 1 (OX 1 ) and orexin 2 (OX 2 ) receptors which are capable of coupling to all heterotrimeric G‐protein subfamilies, but primarily transduce increases in calcium signalling. Orexin neurons are regulated by a variety of transmitter systems and environmental stimuli that signal reward availability, including food and drug related cues. Orexin neurons are also activated by anticipation, stress, cues predicting motivationally relevant information, including those predicting drugs of abuse, and engage neuromodulatory systems, including dopamine neurons of the ventral tegmental area (VTA) to respond to these signals. As such, orexin neurons have been characterized as motivational activators that coordinate a range of functions, including feeding and arousal, that allow the individual to respond to motivationally relevant information, critical for survival. This review focuses on the role of orexins in appetitive motivation and highlights a role for these neuropeptides in pathologies characterized by inappropriately high levels of motivated arousal (overeating, anxiety and substance use disorders) versus those in which motivation is impaired (depression).

Subjects

MeSH terms (MEDLINE)

OrexinsMotivationHypothalamusHumansAnimalsOrexin ReceptorsNeuropeptides

Author keywords

addictiondopamineeatingmesolimbic systemnucleus accumbensorexin hypocretinorexin reserveparaventricular nucleusventral tegmental area

Substances

OrexinsOrexin ReceptorsNeuropeptides

Authors and institutions

  • Department of Physiology and Pharmacology, Hotchkiss Brain Institute, The University of Calgary, Calgary, Alberta, Canada.
  • School of Biomedical Sciences and Pharmacy, University of Newcastle, University Drive, Callaghan, New South Wales, Australia.
  • The Hunter Medical Research, New Lambton Heights, New South Wales, Australia.
  • Department of Psychiatry and Brain Health Institute, Robert Wood Johnson Medical School, Rutgers University, Piscataway, New Jersey, USA.

Funding

  • NIEHS NIH HHS
  • Hunter Medical Research Institute
  • NIDA NIH HHS
  • New Jersey Health Foundation
  • National Heart Brain and Lung Institute
  • Canada Research Chair
  • NHLBI NIH HHS
  • NSERC Discovery

Cite

APA

Mohammadkhani, A., Mitchell, C., James, M. H., Borgland, S. L., & Dayas, C. V. (2024). Contribution of hypothalamic orexin (hypocretin) circuits to pathologies of motivation. British Journal of Pharmacology, 181(22), 4430-4449. https://doi.org/10.1111/bph.17325

Vancouver

Mohammadkhani A, Mitchell C, James MH, Borgland SL, Dayas CV. Contribution of hypothalamic orexin (hypocretin) circuits to pathologies of motivation. British Journal of Pharmacology. 2024;181(22):4430-4449. doi:10.1111/bph.17325

BibTeX
@article{Mohammadkhani2024,
  author = {Mohammadkhani, Aida and Mitchell, Caitlin and James, Morgan H and Borgland, Stephanie L and Dayas, Christopher V},
  title = {Contribution of hypothalamic orexin (hypocretin) circuits to pathologies of motivation},
  journal = {British Journal of Pharmacology},
  year = {2024},
  volume = {181},
  number = {22},
  pages = {4430--4449},
  doi = {10.1111/bph.17325}
}
Start for free →